Search
Search
About
Log in
Join
Experiences with
Ibrutinib
Posts
Communities
1,970 public posts
Filter results
ASH 2012 Interview with Dr. Rick Furman
This is one of my favorite interviews as it tells the story of the phase 1 trials of
ibrutinib
and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See http://bkoffman.blogspot.com
This is one of my favorite interviews as it tells the story of the phase 1 trials of
ibrutinib
and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See http://bkoffman.blogspot.com
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
Saying No to Chemo. Part 1
On a personal note, I am continuing to do well on my
ibrutinib
trial. Thanks and be well Brian
On a personal note, I am continuing to do well on my
ibrutinib
trial. Thanks and be well Brian
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
News about the new drugs being trialled for CLL.
Plus several long articles about the newer drugs such as
Ibrutinib
with comments from Claire Dearden, MD, the head of the CLL Unit at the Royal Marsden Hospital in London.
Plus several long articles about the newer drugs such as
Ibrutinib
with comments from Claire Dearden, MD, the head of the CLL Unit at the Royal Marsden Hospital in London.
Kwenda
in
CLL Support
11 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Hi everyone , how far do you think we are away from not using FCR has the first line treatment , and drugs such as ibrutinib or cal - 101
I know some
ibrutinib
trials has began in the uk also consultants going through NICE to make this drug available to some patients Stewie Watch and wait Student nurse
I know some
ibrutinib
trials has began in the uk also consultants going through NICE to make this drug available to some patients Stewie Watch and wait Student nurse
stewie
in
CLL Support
11 years ago
ASH 2012 Interviews Part 3 Dr. John Byrd on Ibrutinib
Byrd where he discusses some of the details of what we know about
ibrutinib
therapy so far.
Byrd where he discusses some of the details of what we know about
ibrutinib
therapy so far.
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
Interview with Dr. Byrd at ASH 2012 on new medications, especially ibrutinib
Hi, Dr Byrd is my physician at OSU and arguably has more clinical experience with
ibrutinib
than anyone else in the world. On my blog ( http://bkoffman.blogspot.com ) tonight, I posted the first of a 4 part interview done at ASH 2012. It's 10 minutes well spent.
Hi, Dr Byrd is my physician at OSU and arguably has more clinical experience with
ibrutinib
than anyone else in the world. On my blog ( http://bkoffman.blogspot.com ) tonight, I posted the first of a 4 part interview done at ASH 2012. It's 10 minutes well spent.
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
New prognostic markers and better understanding of risk groups?
ABT-199,
ibrutinib
, CAL-101, GA-101 .Will traditional markers hold up in the "new era?" There are many questions.
ABT-199,
ibrutinib
, CAL-101, GA-101 .Will traditional markers hold up in the "new era?" There are many questions.
HAIRBEAR_UK
Administrator
in
CLL Support
11 years ago
CLL patient advocate and journalist, Andrew Schorr shares his story with CLL patient Dr Brian Koffman from the other side of the lens.
feature=player_embedded&v=S-3tqTQEvJk In Future posts Dr Brian Koffman will share the interview Andrew Schorr did with him at ASH about his
ibrutinib
trial.
feature=player_embedded&v=S-3tqTQEvJk In Future posts Dr Brian Koffman will share the interview Andrew Schorr did with him at ASH about his
ibrutinib
trial.
HAIRBEAR_UK
Administrator
in
CLL Support
11 years ago
More from ASH about some of the novel therapies in trial
Ibrutinib
, GS 1101 and ABT-199 are changing the CLL treatment landscape, plus antibody therapies such as GA 101 and novel therapies such as TRUO16 and the exciting T cell mediated therapies in research CART etc. All of these are moving away from toxicity treatments for the future.
Ibrutinib
, GS 1101 and ABT-199 are changing the CLL treatment landscape, plus antibody therapies such as GA 101 and novel therapies such as TRUO16 and the exciting T cell mediated therapies in research CART etc. All of these are moving away from toxicity treatments for the future.
HAIRBEAR_UK
Administrator
in
CLL Support
11 years ago
ASH 2012 Ibrutinib Press Conference
Patient Power Video http://www.patientpower.info/video/results-suggest-a-potential-breakthrough-in-cll?autoplay=1
Patient Power Video http://www.patientpower.info/video/results-suggest-a-potential-breakthrough-in-cll?autoplay=1
Cllcanada
Top Poster CURE Hero
in
CLL Support
11 years ago
1
...
98
99
50
60
70
80
90
Filter results
Clear filters
Posted in
All communities
CLL Support
1881 results
CLL America Support
29 results
Non Hodgkin's Lymphoma Friends
29 results
View top 10 communities
Sort by
Most Relevant
Newest